Insights

Strategic partnerships Terray Therapeutics has an active collaboration history with major industry players (notably Gilead) and recent high-profile hires, indicating readiness for large-scale partnerships and co-development deals that could be leveraged to introduce complementary technologies, expand target portfolios, or co-create novel small molecule pipelines.

Platform collaboration The company recently launched an experiment-driven machine learning platform for small-molecule discovery, creating an attractive entry point for joint R&D programs, data-sharing agreements, or SaaS-like licensing of their computational/experimental platform to accelerate partner programs.

Financial scale With substantial funding (funding total around 225M) and a recent $120M Series B, Terray presents a credible partner for co-investment, milestone-driven financing, or strategic equity partnerships that can de-risk early-stage collaborations and scale joint programs.

Tailored discovery Terray blends ultra-high throughput experimentation with AI, automation, and nanotechnology to accelerate small molecule discovery, signaling opportunities to position as a preferred supplier for target-driven hit discovery, lead optimization, or platform-enabled contract research for biotech and pharma companies seeking faster timelines.

Executive access Recent leadership appointments (Chief Business Officer and Scientific Advisory Board additions) indicate a focus on business development and scientific credibility, suggesting proactive outreach with executives could yield strategic conversations around pipeline prioritization, licensing options, and joint ventures.

Similar companies to Terray Therapeutics

Terray Therapeutics Tech Stack

Terray Therapeutics uses 8 technology products and services including Sage Intacct, SOLIDWORKS, Ansible, and more. Explore Terray Therapeutics's tech stack below.

Media & News

Terray Therapeutics's Email Address Formats

Terray Therapeutics uses at least 7 email formats:
Terray Therapeutics Email FormatsExamplePercentage
First@terraytx.comJohn@terraytx.com
52%
First.Last@terraytx.comJohn.Doe@terraytx.com
32%
FLast@terraytx.comJDoe@terraytx.com
15%
First.MiddleLast@terraytx.comJohn.MichaelDoe@terraytx.com
1%
First@terraytherapeutics.comJohn@terraytherapeutics.com
70%
First.Last@terraytherapeutics.comJohn.Doe@terraytherapeutics.com
29%
First.Middle@terraytherapeutics.comJohn.Michael@terraytherapeutics.com
1%

Frequently Asked Questions

What is Terray Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Terray Therapeutics's official website is terraytx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Terray Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Terray Therapeutics's annual revenue is estimated to be $50M - $100M.

What is Terray Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Terray Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Terray Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Terray Therapeutics has approximately 144 employees across 5 continents, including North America, Africa and Asia. Key team members include Director - Medicinal Chemistry: J. G., Director Translational Biology: C. L. and Manager, Compound Management: D. R. Explore Terray Therapeutics's employee directory with LeadIQ.

What industry does Terray Therapeutics belong to?

Minus sign iconPlus sign icon
Terray Therapeutics operates in the Biotechnology Research industry.

What technology does Terray Therapeutics use?

Minus sign iconPlus sign icon
Terray Therapeutics's tech stack includes Sage Intacct, SOLIDWORKS, Ansible, Apache Airflow, Docker, Kubernetes, Snowflake and Microsoft Active Directory.

What is Terray Therapeutics's email format?

Minus sign iconPlus sign icon
Terray Therapeutics's email format typically follows the pattern of First@terraytx.com. Find more Terray Therapeutics email formats with LeadIQ.

How much funding has Terray Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Terray Therapeutics has raised $225M in funding. The last funding round occurred on Apr 01, 2025 for $120M.

When was Terray Therapeutics founded?

Minus sign iconPlus sign icon
Terray Therapeutics was founded in 2018.
Terray Therapeutics logo

Terray Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Terray Therapeutics is a biotechnology company based in Pasadena, California, focused on transforming how small molecule therapeutics are discovered and developed. Its approach integrates extensive experimentation with computational methods to generate large volumes of precise, design-specific data through iterative cycles, with the aim of improving cost, speed, and success in drug discovery. The company operates at a mid-sized scale, reflecting its growing research footprint.

Its customers are pharmaceutical developers and other partners seeking novel small molecule therapies. In 2025 Terray launched an experiment-driven platform to accelerate small molecule discovery.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $225M

    Terray Therapeutics has raised a total of $225M of funding over 7 rounds. Their latest funding round was raised on Apr 01, 2025 in the amount of $120M as a Debt Financing.

  • $50M - $100M

    Terray Therapeutics's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.